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Abstract
Objectives: The aim of this study is to compare the analgesic and anti-inflammatory effects of the local postoperative 
administration of a single 12-mg dose of betamethasone after the surgical removal of impacted lower third molars. 
Study design: A split-mouth, triple-blind, randomized, placebo-controlled clinical trial of 25 patients requiring 
the surgical removal of symmetrical lower third molars was performed. In the experimental side, a 12-mg dose of 
betamethasone was administered submucosally after the surgical procedure, while in the control side a placebo 
(sterile saline solution) was injected in the same area. To assess postoperative pain, visual analogue scales and the 
consumption of rescue analgesic were used. The facial swelling and trismus were evaluated by measuring facial 
reference distances and maximum mouth opening. 
Results: There were no significant differences between the two study groups regarding postoperative pain, facial 
swelling and trismus. 
Conclusions: The injection of a single dose of betamethasone does not seem to reduce pain, facial swelling and 
trismus after impacted lower third molar removal when compared to placebo. 
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Introduction
The most common postoperative complications of im-
pacted lower third molar extractions are pain, trismus 
and facial swelling (1).Many papers have suggested sev-
eral measures to prevent and treat these complications. 
Among these, the administration of non-steroidal anti-
inflamatory drugs (NSAID) is considered to be one of 
the most useful (2,3). Nevertheless, some reports have 
showed that, a significant percentage of patients need 
additional medication to adequately control pain and 
swelling after this surgical procedure (2,3).
The intraoperative administration of corticosteroids is 
a pharmacologic approach that allows a reduction of 
the postoperative morbidity by inhibiting the synthesis 
and/or release of pro-inflammatory and inflammatory 
mediators in a variety of surgical procedures, with a re-
duction of fluid transudation and therefore edema (4). 
However, the prolonged use of corticosteroids can delay 
healing, increase patient susceptibility to infection and 
may cause adrenal suppression (5).
 The absolute contraindications to corticosteroid use 
include patients with tuberculosis, active viral or fun-
gal infections, active acne vulgaris, primary glaucoma, 
history of acute psychosis or psychopathic tendencies 
and allergies (6). Since these contraindications refer to 
chronic corticosteroid use, such drugs should be avoid-
ed in patients with these problems (7).
A recent systematic review has concluded that there is no 
clear practice consensus concerning the use of corticos-
teroids in third molar removal because published studies 
lack comparability with regard to patient selection, dosage, 
timing, type, and route of administration of steroid (8). 
Celestone Cronodose® (Schering-Plough S.A.; Madrid, 
Spain) is an injectable solution that contains two betam-
ethasone esters, one of high solubility and other with a 
slow absorption, achieving a strong anti-inflammatory, 
anti-rheumatic and anti-allergic effect. This preparation 
provides an immediate therapeutic effect due to betam-
ethasone disodium phosphate (6 mg), a fast-acting solu-
ble ester. The prolonged effect is due to betamethasone 
acetate (6 mg), which is slowly and gradually absorbed. 
This way, with a single injection, a rapid, prolonged and 
uniform steroid effect can be obtained (9). Futhermore, 
the selected corticosteroid should have scant mineralo-
corticoid effects and great biological activity.
The aim of this clinical trial was to evaluate the effect 
of the submucosal injection of a single 12-mg dose of 
betamethasone following the surgical extraction of 
impacted lower third molars under local anesthesia on 
pain, facial swelling and trismus.
Patient and Methods
A randomized, triple-blind, split mouth, placebo-con-
trolled clinical trial was performed in 25 patients. All 
participants were submitted to the surgical removal 
of both impacted lower third molars between the May 
2008 and June 2010. This trial was design complying 
with the CONSORT guidelines for clinical trials (10).
The study was approved by the Research Ethics Com-
mittee (CEIC) of the Dental Clinic of the University of 
Barcelona. Before enrolment, all patients were explained 
the objectives, implications and possible complications 
of this clinical trial and agreed to participate by signing 
an informed consent. The main inclusion criterion was 
the presence of symmetrical impacted lower third mo-
lars that required surgical removal. 
Exclusion criteria were patients aged below 18 years or 
over 35 years, patients with significant systemic dis-
eases (ASA III or ASA IV), pregnancy, contraindica-
tions for corticosteroid treatment, history of allergy to 
paracetamol or magnesium metamizol, lactose intoler-
ance, gastrointestinal pathology, presence of symptoms 
associated to the third molar the week prior to extrac-
tion and history of analgesic and/or anti-inflammatory 
drugs intake 10 days before. Antibiotic prophylaxis was 
not performed. Sequentially numbered envelopes were 
used to warrant allocation concealment. 
The extractions were all of similar technical difficulty, 
and a panoramic radiography showed positioning of the 
teeth to be symmetrical (regarding Pell & Gregory and 
Winter classifications). All patients included required 
bone removal and tooth sectioning to achieve extrac-
tion. Informed consent was obtained in all cases for 
both surgical extraction and inclusion in the study.
The extractions were carried out by two third-year resi-
dents of the Master degree program of Oral Surgery and 
Implantology (University of Barcelona) using a similar 
surgical technique. Each resident performed both ex-
tractions on the same patient, with a wash-out period 
of 1 month.
The extraction of impacted lower third molars was per-
formed under local anesthesia with articaine 4% and 
epinephrine 1:100.000 (Artinibsa; Inibsa, Lliça de Vall, 
Spain). The surgical field and all the surgical material 
were sterile. The surgeon raised a full-thickness flap, 
which was protected by the Minnesota retractor. A lin-
gual flap retraction using a Freer periosteal elevator was 
only performed when the surgeon consider it to be neces-
sary. Sterile low-speed (20.000 rpm) handpieces and ster-
ile saline solution were used for bone removal and tooth 
sectioning when necessary. To close the wound, 3-0 silk 
sutures (Silkam, Braun; Tuttlingen, Germany) were used. 
The surgical technique was similar to that described by 
Leonard (11). The duration of surgery was calculated 
from the time of incision to placement of the last suture. 
The duration of the shortest intervention was required to 
be 75–100% that of the longest intervention.
No medication was given before extraction. The follow-
ing medication was prescribed: an antibiotic (amoxi-
cillin 750 mg, tablets (Clamoxyl®, GlaxoSmithKline, 
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Madrid, Spain) p.o every 8 hours for 7 days), an an-
algesic (paracetamol 1 g, tablets (Gelocatil®, Gelos® 
SL; Barcelona, Spain) p.o every 8 hours for 5 days), a 
mouthrinse (0.12% chlorhexidine mouthwash 2 times a 
day for 15 days) and a rescue medication (magnesium 
metamizol 575 mg, tablets (Nolotil®, Boehringer Ingel-
heim España S.A.; Sant Cugat, Spain) 2 capsules p.o 
every 8 hours in case of pain). All patients were told not 
to apply ice during the postoperative period, in order to 
avoid possible bias.
The injection of corticosteroids in the right or left side 
was chosen randomly, using a predetermined sequence 
of random numbers in blocks (generated in www.rand-
omization.com).
Following removal of the third molar in the corticoster-
oidal group, 12 mg of betamethasone (Celestone Crono-
dose®, Schering-Plough S.A.; Madrid, Spain) was in-
jected submucosally through an intraoral approach. The 
control group received a sterile saline solution. The in-
jection of the drug was carried out by a third person (not 
directly involved in the surgery nor in the postoperative 
visits), thus ensuring blinding of the study. The patients 
rated pain on a 10-cm visual analog scale, the extreme 
scores being ‘no pain’ and ‘worst pain imaginable’. Pain 
was assessed 6 hours after the end of surgical proce-
dure, and then once a day during the next 3 days. The 
patients were also instructed to register the total amount 
of rescue medication needed every day and possible ad-
verse events.
Facial swelling and trismus were registered at 48 hours 
and 7 days after the extraction by a blinded surgeon. Tris-
mus was assessed by measuring the maximum mouth 
opening with a calliper, and facial swelling was given by 
the following facial distances: gonion-lip commissure, 
gonion-external canthus of the eye, tragus-lip commis-
sure (12). The following variables were also gathered: 
Age, gender, smoking habit, position of the third molar 
(Pell and Gregory and Winter classifications), bone reten-
tion, bone removal and tooth sectioning.
All patients, the statistician and the surgeons who per-
formed the extraction and follow-up examinations were 
unaware of the medication given in each extraction. The 
sample size was calculated using the statistical program 
G * Power 3.0. (Heinrich-Heine-Universität, Düssel-
dorf, Germany)8, with an alpha value of 0.05, a statisti-
cal power of 80%, and in order to detect differences of 
4 mm in gonion-lip commissure distance.
The data obtained was analyzed using SPSS 19.0 statisti-
cal package (SPSS Inc., Chicago, IL, USA) for Microsoft 
Windows. Where distribution was compatible with nor-
mality, the mean and standard deviation (SD) were used. 
Pain, trismus, and facial edema were analyzed by ANO-
VA for a repeated-measures test. Rescue medication was 
assessed by Student t-tests. The significance level was set 
at p < 0.05 with a confidence interval of 95%.
Results
A total of 30 patients were enrolled, although 5 were 
lost because they did not attend follow-up visits. Fig-
ure 1 shows a flow chart of the recruitment of partici-
pants16. Therefore the results were based in the analysis 
of a total of 50 mandibular third molars extractions (25 
participants), 25 in the experimental group and 25 in the 
control group as each patient act as its own control. The 
study groups were similar regarding bone retention of 
the third molar and duration of surgery (t-student tests; 
p>0.05). The main clinical variables of the sample can 
be observed in table 1.
Table 2 shows the results for pain intensity, rescue med-
ication intake, facial swelling and mouth opening vari-
ables in the 2 study groups. The peak pain occurred at 6 
hours and there were no significant differences between 
the two groups regarding pain intensity and rescue med-
ication intake in the first 3 postoperative days (ANOVA 
repeated measures and t-student tests; p>0.05). When 
the analysis was made for each individual pain assess-
ment time, once again no significant differences were 
found (t-student tests; p>0.05).
The reference distances gonion-lip commissure, gonion-
external canthus of the eye, tragus-lip commissure, and 
mouth opening were similar in both groups (ANOVA 
repeated measures and t-student tests; p>0.05).
No adverse effects related to the experimental medica-
tion or to any of the prescribed drugs were registered.
Discussion
The third molar surgical extraction is often related with 
severe postoperative discomfort. Thus, many clinicians 
routinely use corticosteroids in order to prevent and re-
duce the postsurgical sequelae (4).
Several papers have shown a significant reduction of 
trismus, pain and facial swelling when corticosteroids 
are administered, but few reports use the local injection 
of these drugs in the third molar region (8,13) .
Different administration routes have been used for these 
drugs in oral surgery. The oral route is more comfortable 
for the patient and ensures rapid and almost complete 
absorption, but its efficacy compared with parenteral 
administration is questionable (6). The intravenous ad-
ministration affords excellent and immediate plasma 
drug levels, although this route is not frequently used 
in an outpatient environment. Some studies show that a 
single preoperative intravenous dose offers almost im-
mediate benefit in terms of pain, swelling and trismus, 
but frequently a supplemental dosing is needed, in or-
der to ensure optimum clinical efficacy (6,14). With the 
present corticosteroid it was expected a significant and 
sustained anti-inflammatory effects.
The studies conducted to date involved low doses and 
brief periods of observation (6,8). The intramuscular 
route affords good plasma drug concentrations and pro-
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Fig. 1. CONSORT flow chart of the participants in the trial.
Variables Number (percentage)
Gender
Male 13 (52%)
Female 12 (48%)
Age (years) 23.44±5.14
Smoking habit
No 17 (68.0%)
< 20 cig/day 7 (28.0%)
> 20 cig/day 1 (4.0%)
Bone retention
Complete 0 (0%)
Partial 25 (100%)
Pell & Gregory position
A 24 (48.0%)
B 24 (48.0%)
C 2 (4.0%)
Pell & Gregory position
I 0 (0%)
II 48 (96.0%)
III 2 (4.0%)
Winter position
Horizontal 22 (44.0%)
Mesioangular 10 (20.0%)
Vertical 12 (24.0%)
Distoangular 6 (12.0%)
Bone removal
Yes 25 (100%)
No 0 (0%)
Tooth sectioning
Yes 25 (100%)
No 0 (0%)
Table 1. Main clinical features of the patients. 
longed anti-inflammatory action with a single pre- or 
postoperative dose (15).
The local administration of the corticosteroid is con-
venient for the surgeon, since the injection is carried 
out in close to the surgical area, and also for the patient, 
since the injection is painsless and it does not depend on 
the patient compliance (1,12,16).
Antunes et al. (17) and Boonsiriseth et al. (18) compared 
the effect of two routes of administration of 8mg of dex-
amethasone on pain, trismus and edema in impacted third 
molar surgery, obtaining effective and similar results.
To our knowledge, it has not been published a single 
study that uses this corticosteroid association in the 
management of pain, trismus and swelling after third 
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Mean ± standard deviation
t-student (p)Betamethasone group 
(mean±SD)
Control group 
(mean±SD)
VAS pain intensity (mm)
6 hours 35.4±26.3 38.9±27.8 0.840
24 hours 20.8±19.8 26.8±23.0 0.171
48 hours 12.6±12.2 17.6±19.6 0.210
72 hours 8.4±11.8 14.0±23.2 0.082
Rescue medication intake 
(capsules) Total 7.3±5.6 6.5±4.5 0.590
Gonion-lip commissure (mm)
Preoperative 89.0±6.9 89.4±6.1 0.388
48 hours 93.1±7.3 93.6±7.9 0.529
7 days 89.8±6.9 90.5±7.2 0.641
Tragus-lip commissure (mm)
Preoperative 112.5±5.7 113.4±4.7 0.468
48 hours 115.6±5.7 116.9±6.3 0.907
7 days 113.9±5.5 114.8±5.3 0.554
Gonion-external canthus of 
the eye (mm)
Preoperative 103.9±7.0 104.2±6.8 0.998
48 hours 106.8±8.8 107.9±8.0 0.380
7 days 104.6±7.5 105.1±6.9 0.741
Mouth opening
Preoperative 53.1±6.0 52.0±5.9 0.936
48 hours 43.7±9.1 40.6±12.3 0.123
7 days 49.3±7.8 48.1±7.8 0.941
Table 2. Comparison between the 2 study groups for postoperative pain, rescue medication intake, mouth opening and facial swelling. 
molar surgery. The present study is a unique, prospec-
tive, randomized, triple-blind, split mouth, placebo-
controlled clinical trial experimenting this association 
in surgery in order to determine its effectiveness in the 
reduction of postoperative discomfort.
Previously, Micó-Lorens et al. (15) injected 40 mg of 
methylprednisolone into the gluteal zone following the 
extraction of impacted third molars, and reported good 
results 2 days after the operation in terms of swelling, 
pain and trismus, but after 7 days the differences were 
no longer significant (15). Likewise, Grossi et al. (12) 
reported beneficial effects on facial edema 48 hours af-
ter surgery, when 2 different concentrations (4mg and 
8mg) of dexamethasone sodium phosphate were admin-
istered submucosally. However, no statistically signifi-
cant effects were found regarding pain and trismus, and 
the results were quite similar for the 2 dosage regimens 
of dexamethasone (12).
Vegas-Bustamante et al. (1) demonstrated the efficacy 
of methylprednisolone, as a single 40mg dose, injected 
into the masseter muscle after the extraction of impact-
ed lower third molars, in the reduction of swelling, tris-
mus and pain.
Klongnoi et al. (16) alson reported that a single intramus-
cular injection of 8 mg dexamethasone can reduce postop-
erative facial swelling and pain, without affecting trismus 
after surgical extraction of impacted lower third molars.
Nevertheless, our results contrast with this studies, 
since no significant results were found in the reduction 
of postoperative discomfort. This could be a result of 
different factors: in the calculation of the sample size 
it was not taken in account the dropout rate which de-
creased the number of subjects or the flap elevation and 
tissue manipulation during the surgery that could have 
affected the concentration of the injected drug and im-
peded its absorption (17).
Another limitation was that only a single third molar was 
removed at each procedure, and the effect observed in the 
present study might be different for more extensive and 
lengthier procedures, as also referred Antunes et al.( 17). 
Further studies, with a bigger sample size and a greater 
technical difficulty could show significant results.
The method used in the current study to measure fa-
cial swelling and trismus (calipers and silk thread) is 
valid, easy to use and inexpensive. However it is not the 
most sensitive method and could generate some bias. 
Other methodological approaches have also been de-
scribed, such as clinical observation, subjective palpa-
tion, and the use of malleable metal rods, photographic 
techniques, or ultrasounds (14,19-21). Other authors 
Med Oral Patol Oral Cir Bucal. 2014 Jan 1;19 (1):e49-54.                                                             Effect of the local administration of betamethasone after impacted lower third molar extraction
e54
like Esen et al. (14) also used a computed tomography 
to evaluate the facial edema which is, in our opinion, a 
highly reprehensible procedure, since it is being used an 
ionizing radiation only to evaluate the facial edema.
The results of this study indicate that there is no significant 
benefit of a single intramuscular dose of betamethasone 
over placebo concerning pain reduction, facial swelling 
and trismus after impacted lower third molar removal.
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